Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stable, protracted GLP-1/glucagon receptor co-agonists for medical use

Stable, protracted GLP-1/glucagon receptor co-agonists for medical use

US Patent 9751927 · Granted Sep 5, 2017

Estimated economic value: $19,715,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-sensitive albumin-binding derivatives2025
Amylin receptor agonists2024
Amylin receptor agonists2024
Co-agonists of the GLP-1 and amylin receptors2024
Glucose-sensitive albumin-binding derivatives2023
Compounds for treatment of obesity2023
GIP derivatives and uses thereof2023
Glucose sensitive insulins and uses thereof2023
Double-acylated GLP-1 derivatives2022
Glucose-sensitive albumin-binding derivatives2021
Double-acylated GLP-1 derivatives2021
Double-acylated GLP-1 derivatives2021